Skip to main content

Before, during, and beyond treatment.

The programs you want.

The support you need.

Before, during, and beyond treatment.

The programs you want.

The support you need.

Looking for product support?

NovoSecure™

NovoSecure™, a program to help eligible patients navigate challenges along the hemophilia journey, is here to help.

Esperoct® patient support
Esperoct® patient support

Esperoct® packaging

Trial Prescription Program.

Get the details of the Novo Nordisk free Trial Prescription Program when you call 1-844-668-6732 and talk with a NovoSecure™ specialist.a

aPatients who have been prescribed a Novo Nordisk hemophilia and rare bleeding disorder product for an FDA-approved indication, and who have commercial insurance or who are uninsured, may be eligible to receive a limited supply of free product. Patients who participate in any government, state, or federally funded medical or prescription benefit program, including Medicare, Medicaid, Medigap, VA, DOD, and TRICARE, including patients who participate in a managed Medicaid program or have Medicaid as secondary insurance, are not eligible to receive product support. Product is provided at no cost to the patient or the HCP, is not contingent on any product purchase, and the patient and HCP must not: (1) bill any third party for the free product, or (2) resell the free product.

Co-pay Assistance.

Life happens. When it does, you may need help with your co-pay costs for Esperoct®.b

bNovo Nordisk Hemophilia and Rare Bleeding Disorders Copay/Coinsurance Terms and Conditions: Enrolled patients are eligible for up to $12,000 in co-pay/coinsurance assistance per calendar year for each NNI hemophilia or rare bleeding disorder product. Assistance is retroactive to 60 days. Patients must be commercially insured and may not be participating in any government, state, or federally funded medical or prescription benefit programs, including Medicare, Medicaid, Medigap, VA, DOD, and TRICARE, including patients who participate in a managed Medicaid program or have Medicaid as secondary insurance. Uninsured, cash-paying patients are not eligible to participate. Patients are eligible to receive co-pay/coinsurance assistance on an annual basis (12 months). Offer good only in the USA, Puerto Rico, Guam, Saipan, and Virgin Islands with participating pharmacies and cannot be redeemed at government-subsidized clinics. Void where taxed, restricted, or prohibited by law. The Savings Card will no longer be valid for residents of Massachusetts. Patient is responsible for complying with any insurance carrier co-payment disclosure requirements, including disclosing any savings received from this program. Re-confirmation of information may be requested periodically to ensure accuracy of data and compliance with terms. This is not an insurance program. Novo Nordisk reserves the right to rescind, revoke, or amend this offer without notice at any time. Non-medication expenses, such as ancillary supplies or administration-related costs, are not eligible. Must have a current prescription for an FDA-approved indication.


Product Assistance Program (PAP).

Eligible applicants can receive medication from the Novo Nordisk PAP. Get program details by calling 1-844-668-6732 or apply by downloading and completing this form.c

cThe Novo Nordisk Patient Assistance Program (PAP) is administered by NovoSecure™. To qualify for the PAP, patients must demonstrate financial need and must have attempted to find alternative reimbursement. Several factors are considered in evaluating financial need, including cost of living, size of household, and burden of total medical expenses. If the applicant qualifies under the PAP guidelines, a limited supply of the requested medication(s) will be shipped to the patient. Patients who qualify for PAP may be eligible to receive the prescribed Novo Nordisk product, for up to 1 year from the approval date. Product limits vary.


Going beyond financial assistance.

Tools to support your doctor discussions, infusion scheduling, and on-the-go lifestyle.

Esperoct® add to calendar tool.

The science is clear. Staying committed to prophylaxis treatments reduces bleeding episodes and maintains joint health. Don’t miss a treatment! Just click the “add a reminder” link and pick your start date to add infusion reminders to your calendar every four days.

Male and female Hemophilia Community Liaisons
Male and female Hemophilia Community Liaisons

Talk to us.

Your Hemophilia Community Liaison (HCL) is there to answer your questions about our product and educational programs—or point you in the right direction for answers. Contact your HCL for more information.

Esperoct® email newsletter

Stay informed.

Sometimes you want your information delivered to your inbox for easy access. Sign up today for Esperoct® news and don’t let a good resource go to waste!

Esperoct® FAQs
Esperoct® FAQs

Your questions, answered.

Question: What is NovoSecure™?

Answer: NovoSecure™ is a support program created to help you along your journey. NovoSecure™ provides assistance with coordinating insurance coverage, paying for treatment, and more. From verifying coverage to re-authorizing your prescription, we may be able to help.

Question: What is the Product Assistance Program (PAP)?

Answer: PAP provides free medication to eligible applicants. Should you qualify under the PAP guidelines, the prescribed dose of Esperoct® will be shipped to your home.d There is no registration charge or monthly fee for participating. If you’d like to see if you qualify, download and fill out the PAP application form.c

dProduct limits vary.

Selected Important Safety Information

Who should not use Esperoct®?
  • You should not use Esperoct® if you are allergic to factor VIII or any of the other ingredients of Esperoct® or if you are allergic to hamster proteins
What is the most important information I need to know about Esperoct®?
  • Do not attempt to do an infusion yourself unless you have been taught how by your healthcare provider or hemophilia treatment center
  • Call your healthcare provider right away or get emergency treatment right away if you get any signs of an allergic reaction, such as: hives, chest tightness, wheezing, dizziness, difficulty breathing, and/or swelling of the face

What is Esperoct®?

Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei] is an injectable medicine to treat and prevent or reduce the number of bleeding episodes in people with hemophilia A. Your healthcare provider may give you Esperoct® when you have surgery

  • Esperoct® is not used to treat von Willebrand Disease

Important Safety Information

Who should not use Esperoct®?
  • You should not use Esperoct® if you are allergic to factor VIII or any of the other ingredients of Esperoct® or if you are allergic to hamster proteins
What is the most important information I need to know about Esperoct®?
  • Do not attempt to do an infusion yourself unless you have been taught how by your healthcare provider or hemophilia treatment center
  • Call your healthcare provider right away or get emergency treatment right away if you get any signs of an allergic reaction, such as: hives, chest tightness, wheezing, dizziness, difficulty breathing, and/or swelling of the face
What should I tell my healthcare provider before using Esperoct®?
  • Before taking Esperoct®, you should tell your healthcare provider if you have or have had any medical conditions, take any medicines (including non-prescription medicines and dietary supplements), are nursing, pregnant or planning to become pregnant, or have been told that you have inhibitors to factor VIII
  • Your body can make antibodies called “inhibitors” against Esperoct®, which may stop Esperoct® from working properly. Call your healthcare provider right away if your bleeding does not stop after taking Esperoct®
What are the possible side effects of Esperoct®?
  • Common side effects of Esperoct® include rash or itching, and swelling, pain, rash or redness at the location of infusion

Please click here for Prescribing Information.

Esperoct® is a prescription medication.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.